Navigation Links
Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
Date:10/18/2011

SEATTLE, Oct. 18, 2011 /PRNewswire/ -- Immune Design Corp. (IDC) announced today that Guy F. Cipriani, MBA will be joining the company as its new Chief Business Officer.  In the position, Mr. Cipriani will leverage more than 12 years of pharmaceutical and biotechnology industry experience to lead strategy and business development activities for the company's rapidly advancing pipeline of novel therapeutic vaccines and immunotherapies for infectious diseases, cancer and allergy.

(Logo:  http://photos.prnewswire.com/prnh/20111018/SF88252LOGO)

Most recently, he was Vice President of Business Development and a member of senior management at Cardiome Pharma Corp. in Vancouver, B.C. Canada.  Prior to Cardiome, Mr. Cipriani served as Director of Business Development for TransForm Pharmaceuticals, Inc., a biotechnology company based in Lexington, MA, that was acquired by Johnson and Johnson in April 2005. He also spent 5 years in Corporate Business Development at Eli Lilly and Company in Indianapolis, IN, and previously as a management consultant with Accenture in Chicago, IL.  Mr. Cipriani received his MBA from the Kellogg School of Management at Northwestern University and holds a B.S.E.E., High Honors from Rochester Institute of Technology.

"We are pleased to welcome Guy to our senior management team, as he is an extraordinary individual with great experience.  His demonstrated success in both biotechnology and pharmaceutical companies will be of significant value to IDC as we pursue new collaborations around our two platforms and broad strategic partnerships," said Carlos V. Paya. MD, Ph.D., Chief Executive Officer of IDC.

Mr. Cipriani commented, "I am excited to join an organization with such talented scientists and promising technologies.  I believe that IDC's platforms have tremendous partnering potential and that they can be leveraged in transactions that allow the company to advance aggressively.  I look forward to playing a key role on the senior management team as we take the company forward."

About Immune Design Corp.

Immune Design Corp. is a privately held, clinical-stage biotechnology company based in Seattle, Washington and formed in 2008 to bring together some of the world's leaders in the field of molecular immunology to develop vaccines for the treatment and prevention of infectious and malignant disease.  The company employs advanced and leading edge methods to precisely control the activation and context of antigen presentation by dendritic cells in order to shape the desired adaptive immune response.  This goal is accomplished through the application of two proprietary technology platforms that activate the immune system by distinct mechanisms.

Additional information can be found on the company's website at www.immunedesign.com.

Contact Media:
Cassie Ostrander 206-826-7901 or media@immunedesign.com


'/>"/>
SOURCE Immune Design Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Alcohol-related behavior changes -- blame your immune system
2. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
3. New HIV vaccine approach targets desirable immune cells
4. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
5. Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
6. UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs
7. Amgen and Xencor Enter Option Deal to Co-Develop Xencors Novel Antibody for Autoimmune Diseases
8. NIH scientists show how anthrax bacteria impair immune response
9. Immune Design Grants Adjuvant License to MedImmune
10. Adaptive TCR Launches the immunoSEQ™ Product Line - Visualizing the Immune System With Next-Generation Sequencing.
11. Major disease-vector mosquito reveals the secrets of its immune system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):